Clinical trial Recruiting at 1 site Observational Ages 18 and up

Compare leadless and left bundle branch pacemakers for heart and valve function

Official title: Left Bundle Branch Area Pacing Versus Right Ventricular Leadless Pacing: Acute Effects on Biventricular and Tricuspid Valve Function

Run by Guy's and St Thomas' NHS Foundation Trust · NCT07534917 · Data updated 2026-11-12

This study tests whether leadless pacemakers or left bundle branch area pacing better preserve heart and tricuspid valve function in adults needing a pacemaker.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorGuy's and St Thomas' NHS Foundation Trust
Academic / other
Locations1 site (London)
StatusRecruiting
StartedAugust 18, 2026
Main results expectedJanuary 30, 2029
Study endsJune 1, 2029
Registry record updatedAugust 21, 2026
Trial IDNCT07534917 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) referred for permanent pacemaker implantation with high-degree AV block and preserved ejection fraction (≥50%), at a single UK center.

Probably not a fit

Patients with reduced ejection fraction or significant tricuspid/right ventricular disease, or those unable to undergo MRI/CT/TOE, may not see a benefit from these approaches.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will recruit twenty adults referred for permanent pacemaker implantation and perform an acute, mechanistic comparison of temporary leadless right ventricular pacing and temporary left bundle branch area pacing during the same session before the final device is implanted. Outcomes will focus on biventricular function and tricuspid valve performance to understand the short-term cardiac effects of these newer pacing approaches compared with conventional pacing considerations. Participants have high-degree AV block or are scheduled for AV node ablation and an ejection fraction of 50% or higher. The study is conducted at Guy's and St Thomas' NHS Foundation Trust, with collaboration from King's College London, and uses standard clinical procedures for implantation.

Why it matters

Potential benefit: If successful, the trial could clarify which newer pacing strategy better protects heart function and the tricuspid valve, guiding safer choices for patients needing pacemakers.

How similar studies have gone: Limited data exist comparing leadless pacing and left bundle branch area pacing head-to-head, making this comparative acute study relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients aged ≥18 referred for a permanent pacemaker at a single centre (Guys and St. Thomas' NHS Foundation Trust, UK) with high degree AV block, including Mobitz II and complete heart block, or scheduled AV node ablation, and LVEF ≥50%.

Exclusion Criteria:

* LVEF \<50%, severe TR, severe RV dysfunction, clinically unstable AV block requiring temporary pacing or isoprenaline infusion, left bundle branch block, previous TV annuloplasty or replacement, aortic valve replacement, life expectancy \<1 year, end-stage renal failure, contraindication to cardiac MRI, CT or TOE, pregnancy, contraindication to anticoagulation, peripheral vascular disease precluding insertion of femoral catheters and insufficient capacity to consent to the study.

Where it's running

  • St. Thomas' Hospital
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.